| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 08/18/2004 | EP1446088A2 Intraorally disintegrating valdecoxib compositions prepared by fluid bed granulation process |
| 08/18/2004 | EP1446086A1 Compositions containing oils having a specific gravity higher than the specific gravity of water |
| 08/18/2004 | EP1446008A2 Compositions and methods for controlled release |
| 08/18/2004 | EP1395273A4 Targeted delivery of drugs for the treatment of viral infections |
| 08/18/2004 | EP1212309B1 Caspase inhibitor |
| 08/18/2004 | EP1037636A4 Inhibition of membrane-associated viral replication |
| 08/18/2004 | EP0946744B1 Novel polymeric complexes for the transfection of nucleic acids, with residues causing the destabilisation of cell membranes |
| 08/18/2004 | EP0833920B1 Transferrin receptor genes |
| 08/18/2004 | EP0817851B9 Dna encoding human papilloma virus type 18 |
| 08/18/2004 | EP0706387B1 New procedure to block the replication of reverse transcriptase dependent viruses by the use of inhibitors of deoxynucleotides synthesis |
| 08/18/2004 | EP0619813B1 Linked cyclic polyamines with activity against hiv |
| 08/18/2004 | EP0471011B2 HUMAN LACTOFERRIN cDNA SEQUENCE |
| 08/18/2004 | CN1522259A Cephem compounds |
| 08/18/2004 | CN1522248A Novel butadiene derivatives, process for preparation of the same and intermediates for the synthesis thereof |
| 08/18/2004 | CN1522159A Interferon formulations |
| 08/18/2004 | CN1522155A Method for producing a vaccine |
| 08/18/2004 | CN1522154A Vaccines including as an adjuvant type 1 IFN and process related thereto |
| 08/18/2004 | CN1522153A Novel composition |
| 08/18/2004 | CN1522152A Mycoplasma bovis vaccine and methods of reducing pneumonia in animals |
| 08/18/2004 | CN1522149A Promoting whole body health |
| 08/18/2004 | CN1522145A Compositions and methods for treating vulvovaginitis and vaginosis |
| 08/18/2004 | CN1521193A Chickweed polysaccharide , their production method , use ,combination and preparation |
| 08/18/2004 | CN1521188A Protein extracted from perinereis aibuhitensis, its preparation method and use |
| 08/18/2004 | CN1521184A Hepatitis B virus pre-S mutain, and its preparing process and application |
| 08/18/2004 | CN1521179A Chickweed total flavones , their production method , use and preparation containing the same |
| 08/18/2004 | CN1521178A Process for preparation of 12-dehydroxy azithromycin |
| 08/18/2004 | CN1520883A O, A type bivalent inactivated vaccine for foot-and-mouth disease of ruminant as cattle and sheep |
| 08/18/2004 | CN1520881A Sterilizing preparation for preventing and curing bovine mastitis and preparing process thereof |
| 08/18/2004 | CN1520870A Chinese herbal medicine for treating tinea versicolor |
| 08/18/2004 | CN1520861A Drug for upper respiratory tract infection |
| 08/18/2004 | CN1520856A Use of muskmelon plant extract in pharmacy |
| 08/18/2004 | CN1520848A Dermatophytosis liquid medicine |
| 08/18/2004 | CN1520845A Nasal administration drug for cold |
| 08/18/2004 | CN1520843A Herpesvirus induced disease medicine and its preparation method |
| 08/18/2004 | CN1520839A Compound rheum dispelling preparation |
| 08/18/2004 | CN1520837A Plant extract and compound for treating endotoxin blood disease, and its extraction method and application |
| 08/18/2004 | CN1520836A Pharmaceutical composition for treating hepatitis |
| 08/18/2004 | CN1520825A Use of New Zealand vitexin-1 in preparation of antiviral drug |
| 08/18/2004 | CN1520821A Cefonicid sodium antibacterial composition |
| 08/18/2004 | CN1520816A Sophocarpidine gel preparation and its process |
| 08/18/2004 | CN1520815A Flavescent sophora root drop pills for treating hepatitis B |
| 08/18/2004 | CN1520813A Prion exosomatic inhibition agent |
| 08/18/2004 | CN1162447C Use of SR-15 protein molecules |
| 08/18/2004 | CN1162442C Novel erythromycin derivatives, method of preparation and application as medicines |
| 08/18/2004 | CN1162441C Pluraflavin and derivatives thereof, process for their preparation and use thereof |
| 08/18/2004 | CN1162408C Process for preparing oxazolines from tetrahydrofurans |
| 08/18/2004 | CN1162181C Methods and composition for treatment of immunologically-mediated diseases using cow mycobacterium |
| 08/18/2004 | CN1162162C Chinese medicine preparation for discharging toxic material and curing cold |
| 08/18/2004 | CN1162149C Medicinal compositions for preventing or treating viral myocarditis |
| 08/17/2004 | US6777577 Anticancer agents; antidiabetic agents, anticholesterol agents, cardiovascular disorders, osteoporosis |
| 08/17/2004 | US6777562 Preparation of a trans-calanolide ketone intermediate and chiral separation of calanolide alcohols to give racemic calanolide A |
| 08/17/2004 | US6777544 Polyamide nucleic acid derivatives and agents and processes for preparing them |
| 08/17/2004 | US6777543 13-methyl erythromycin derivatives |
| 08/17/2004 | US6777538 Binding protein |
| 08/17/2004 | US6777444 Nordihydroguaiaretic acid; anticancer agents, viricides |
| 08/17/2004 | US6777440 For therapy of hiv infections; for therapy of aids or arc |
| 08/17/2004 | US6777425 Which binds nucleic acids/dna; gene expression; genetic engineering |
| 08/17/2004 | US6777420 Heterocyclic antibacterial compounds |
| 08/17/2004 | US6777403 Method and structure for inhibiting activity of serine elastases |
| 08/17/2004 | US6777395 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase of hepatitis C virus |
| 08/17/2004 | US6777393 Bacterial and protozoa infections in mammals, fish and birds |
| 08/17/2004 | US6777202 Process for the recombinant production of s-layer proteins in gram-negative host cells |
| 08/17/2004 | US6776978 Aerosol comprises particles comprising at least 10 percent by weight of an opioid, and wherein the opioid is not heroin; opiods include morphine, codeine, naltrexone, buprenorphine, fentanyl, nalbuphine, naloxone, etc. |
| 08/17/2004 | CA2212010C Extracts of shark cartilage, process of production and uses thereof |
| 08/17/2004 | CA2133177C Rapamycin formulations for oral administration |
| 08/17/2004 | CA2133175C Rapamycin formulations for oral administration |
| 08/17/2004 | CA2097702C Dermatomycosis vaccine |
| 08/12/2004 | WO2004067567A2 Anti-dengue virus antibodies, compositions, methods and uses |
| 08/12/2004 | WO2004067563A1 Peptide inhibitors of toxins derived from ll-37 |
| 08/12/2004 | WO2004067560A2 Herpes simplex vp16 protein binding polypeptides |
| 08/12/2004 | WO2004067544A1 Caprazene as novel compound and derivatives thereof, and caprazol as novel compound and derivatives thereof |
| 08/12/2004 | WO2004067537A1 Triazole derivatives and antifungal agents containing the same |
| 08/12/2004 | WO2004067532A1 Novel carbapenem derivatives |
| 08/12/2004 | WO2004067531A1 Hiv-integrase inhibitors, pharmaceutical compositions, and methods for their use |
| 08/12/2004 | WO2004067035A1 Use of avian antibodies |
| 08/12/2004 | WO2004067033A1 Mucosal meningococcal vaccines |
| 08/12/2004 | WO2004067018A1 Bioavailability enhancing activity of carum carvi extracts and fractions thereof |
| 08/12/2004 | WO2004067017A1 Feng-you-jing spray |
| 08/12/2004 | WO2004067008A1 Receptor agonists |
| 08/12/2004 | WO2004066992A1 Medicinal composition for treating infection with drug-resistant staphylococcus aureus |
| 08/12/2004 | WO2004066971A1 Composition for preventive treatment of cold sores |
| 08/12/2004 | WO2004056770A3 Piperidine derivatives useful as ccr5 antagonists |
| 08/12/2004 | WO2004041867A3 Camelidae antibodies against imminoglobulin e and use thereof for the treatment of allergic disorders |
| 08/12/2004 | WO2004026311A3 Use of specific inhibitors of tyrosine kinases for immunomodulation |
| 08/12/2004 | WO2004022032A3 Pharmaceutical dosage form comprising a sulfite compound |
| 08/12/2004 | WO2004002999A3 Modified 2' and 3' -nucleoside produgs for treating flaviridae infections |
| 08/12/2004 | WO2003048337A3 Antibody to latent membrane proteins and uses thereof |
| 08/12/2004 | WO2003037863A3 Substituted indoles, method for production and use thereof for the inhibition of pain |
| 08/12/2004 | WO2003029293A3 Modulators of notch ic protease activity for use in immunotherapy |
| 08/12/2004 | WO2003023028A9 Fungal glyoxal oxidases |
| 08/12/2004 | WO2002090504A3 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use |
| 08/12/2004 | WO2002057408A3 Chitinases, derived from carnivorous plants polynucleotide sequences encoding thereof, and methods of isolating and using same |
| 08/12/2004 | US20040158092 for example, N-(N-acetyl-L-cysteinyl)-S-acetylcysteamine; by protecting the N-acyl-L-cysteine to form an intermediate compound and then coupling intermediate compound with S-acylcysteamine hydrochloride or with thiazolidine |
| 08/12/2004 | US20040158066 Compounds for controlling Helicobacteria |
| 08/12/2004 | US20040157934 Central nervous system disorders; psychological disorders ; administering dosage og dopamine, serotonin and sibutramine |
| 08/12/2004 | US20040157930 Histone deacetylase enzyme-inhibiting derivatives of hydroxamic acid as new cytokine synthesis-inhibiting anti-inflammatory drugs |
| 08/12/2004 | US20040157916 Peptide deformylase inhibitors |
| 08/12/2004 | US20040157914 Pyrrolidinone derivatives |
| 08/12/2004 | US20040157909 Modulating protein kinase signal transduction; anticancer agents |
| 08/12/2004 | US20040157900 Isoxazole-containing thiourea inhibitors useful for treatment of varicella zoster virus |